File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Intervention of artemisinin in macular edema associated with retinal vein occlusion: A protocol for a systematic review and meta-analysis

TitleIntervention of artemisinin in macular edema associated with retinal vein occlusion: A protocol for a systematic review and meta-analysis
Authors
Keywordsartemisinin
central retinal thickness
macular edema
optical coherence tomography angiography
retinal vein occlusion
Issue Date2019
PublisherLippincott, Williams & Wilkins: Various Creative Commons. The Journal's web site is located at http://journals.lww.com/md-journal/pages/default.aspx
Citation
Medicine, 2019, v. 98 n. 25, p. article no. e16044 How to Cite?
AbstractBackground: Artemisinin was discovered to be highly effective antimalarial drugs shortly after the isolation of the parent artemisinin in 1971 in China. It is derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria. Recently, artemisinin has been shown that it might have therapeutic value for several other diseases. The purpose of this review is to assess the efficacy of artemisinin as a treatment for macular edema associated with retinal vein occlusion. Methods and analysis: A systematic literature search will be performed in all available databases to quantitatively review eligible studies and identify all relevant data. We will include randomized controlled trials assessing efficacy of artemisinin as a treatment for macular edema associated with retinal vein occlusion. The methodological qualities, including the risk of bias, will be evaluated using the Cochrane risk of bias assessment tool, while confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Ethics and dissemination: Ethical approval is not required, as this study is based on the review of published research. This review will be published in a peer-reviewed journal and disseminated both electronically and in print. PROSPERO registration number: The protocol for this systematic review has been registered on PROSPERO under the number CRD42019131408.
Persistent Identifierhttp://hdl.handle.net/10722/282859
ISSN
2019 Impact Factor: 1.552
2015 SCImago Journal Rankings: 0.877
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorXu, J-
dc.contributor.authorHao, X-
dc.contributor.authorLu, B-
dc.contributor.authorMing, J-
dc.contributor.authorLi, Xiaoyu-
dc.contributor.authorQi, Y-
dc.contributor.authorXie, L-
dc.date.accessioned2020-06-05T06:22:23Z-
dc.date.available2020-06-05T06:22:23Z-
dc.date.issued2019-
dc.identifier.citationMedicine, 2019, v. 98 n. 25, p. article no. e16044-
dc.identifier.issn0025-7974-
dc.identifier.urihttp://hdl.handle.net/10722/282859-
dc.description.abstractBackground: Artemisinin was discovered to be highly effective antimalarial drugs shortly after the isolation of the parent artemisinin in 1971 in China. It is derived from extracts of sweet wormwood (Artemisia annua) and are well established for the treatment of malaria. Recently, artemisinin has been shown that it might have therapeutic value for several other diseases. The purpose of this review is to assess the efficacy of artemisinin as a treatment for macular edema associated with retinal vein occlusion. Methods and analysis: A systematic literature search will be performed in all available databases to quantitatively review eligible studies and identify all relevant data. We will include randomized controlled trials assessing efficacy of artemisinin as a treatment for macular edema associated with retinal vein occlusion. The methodological qualities, including the risk of bias, will be evaluated using the Cochrane risk of bias assessment tool, while confidence in the cumulative evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Ethics and dissemination: Ethical approval is not required, as this study is based on the review of published research. This review will be published in a peer-reviewed journal and disseminated both electronically and in print. PROSPERO registration number: The protocol for this systematic review has been registered on PROSPERO under the number CRD42019131408.-
dc.languageeng-
dc.publisherLippincott, Williams & Wilkins: Various Creative Commons. The Journal's web site is located at http://journals.lww.com/md-journal/pages/default.aspx-
dc.relation.ispartofMedicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectartemisinin-
dc.subjectcentral retinal thickness-
dc.subjectmacular edema-
dc.subjectoptical coherence tomography angiography-
dc.subjectretinal vein occlusion-
dc.titleIntervention of artemisinin in macular edema associated with retinal vein occlusion: A protocol for a systematic review and meta-analysis-
dc.typeArticle-
dc.identifier.emailLu, B: willalu@hku.hk-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1097/MD.0000000000016044-
dc.identifier.pmid31232939-
dc.identifier.pmcidPMC6636968-
dc.identifier.scopuseid_2-s2.0-85068567690-
dc.identifier.hkuros310188-
dc.identifier.volume98-
dc.identifier.issue25-
dc.identifier.spagearticle no. e16044-
dc.identifier.epagearticle no. e16044-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats